Carerx Corporation · TSX:CRRX

Carerx — Q2 2026 Earnings Presentation

11 slides from Carerx's earnings presentation, Jul 30, 2026

  1. Slide 1: Q2 2026 Earnings Call

    Q2 2026 Earnings Call July 30, 2026

  2. Slide 2: Cautionary Statements

    Cautionary Statements Unless otherwise indicated, references in this presentation to “CareRx”, the “Company”, “we”, “our”, “us”, or similar terms refers to CareRx Corporation, together with its subsidiaries. Any information demonstrating our historical performance is intended only to reflect past pe

  3. Slide 3: Highlights and Growth Momentum

    Highlights and Growth Momentum Puneet Khanna President & Chief Executive Officer

  4. Slide 4: Q2 2026 Summary

    Q2 2026 Summary $93.6 Million $0.4 Million Revenue Net Income $8.0 Million 8.6% Adjusted EBITDA1 Adjusted EBITDA Margin1 91,719 Average Beds Serviced1 1. Adjusted EBITDA is a non-IFRS financial measure and Adjusted EBITDA Margin is a non-IFRS ratio. Average Beds Serviced is a is a supplementary fina

  5. Slide 5: Business Highlights

    Business Highlights • Signed new long-term agreement with large national customer, expected to add approximately 3,000 new beds • Closed St. Catharines, Ontario pharmacy and relocated the serviced beds to Oakville fulfilment centre • Quarterly dividend increased 10% over prior quarter’s dividend to

  6. Slide 6: Operating and Financial Results

    Operating and Financial Results Suzanne Brand Chief Financial Officer

  7. Slide 7: Q2 2026 Financial Results

    Q2 2026 Financial Results As at June 30, 2026 Average Beds Serviced1 91,719 vs 90,048 in Q2 2025 Year-over-year: Revenue $93.6 million vs $91.4 million in Q2 2025 • Revenue increased due to the growth in the number of Average Beds Serviced1 and Adjusted EBITDA1 other initiatives. Adjusted EBITDA Mar

  8. Slide 8: Q2 2026 Balance Sheet

    Q2 2026 Balance Sheet As at June 30, 2026 Quarter-over-quarter: • Net Debt to Adjusted EBITDA1 increased due to Cash an increase in Net Debt1 and decrease in run- rate Adjusted EBITDA1, partially offset by $9.6 million vs $14.8 million at Q1 2026 repayment of term loan Net Debt1 Subsequent to quarte

  9. Slide 9: Final Perspectives

    Final Perspectives Puneet Khanna President & Chief Executive Officer

  10. Slide 10: Final Perspectives

    Final Perspectives • Suzanne Brand elected to Board of Directors of the Senior Living CaRES Fund • Published studies in the Journal of Clinical Microbiology and Antimicrobial Stewardship & Healthcare Epidemiology • CareRx Featured in The Heart Work of Modern Leadership and MIT Sloan Management Revie

  11. Slide 11: Slide 11

CareRx — Q2 2026 Earnings Presentation on 6ix